Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis) Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases Source: International Congress 2015 – A morphological view of chest pathology Year: 2015
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Bacterial colonization in patients with bronchiectasis Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Characteristics of pulmonary MAC disease diagnosed later in follow-up after negative mycobacterial cultures by bronchoscopy Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Infection as a comorbidity of COPD Source: Eur Respir J 2010; 35: 1209-1215 Year: 2010